Form 4: Vita Coco Executive Chairman Sells Shares Under 10b5-1 Plan

Vita Coco Company's Executive Chairman, Michael Kirban, sold 30,000 shares of common stock for approximately $1.25 million under a pre-arranged trading plan.

Summary

• Michael Kirban, Executive Chairman and Director of Vita Coco Company, Inc. (COCO), reported a sale of 30,000 shares of common stock.
• The transaction occurred on September 17, 2025, at a weighted average price of $41.719 per share, totaling approximately $1,251,570.
• The shares were sold in multiple transactions at prices ranging from $41.50 to $42.00 per share.
• This sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Following the transaction, Mr. Kirban beneficially owns 127,629 shares directly and 2,164,730 shares indirectly through the Michael Kirban 2010 Trust (1,549,049 shares) and the Michael Kirban Revocable Trust (615,681 shares).
• He also holds several non-qualified stock options, including 546,000 and 40,950 options fully vested at an exercise price of $10.178.
• Other non-qualified stock options with exercise prices ranging from $15 to $32.78 are subject to various vesting schedules, with the latest vesting beginning on March 3, 2026.

Sentiment

Score: 5

Explanation: The transaction is a sale of shares by a key executive. While executed under a Rule 10b5-1 plan, which indicates pre-planning and not a reaction to new negative information, insider selling can still be interpreted with caution by the market. However, the executive retains a substantial beneficial ownership, mitigating a strong negative sentiment.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reaction to recent non-public information.
• Michael Kirban retains significant beneficial ownership of Vita Coco Company, Inc. common stock (over 2.29 million shares) and substantial stock options (over 1 million options), demonstrating continued alignment with shareholder interests.

Negatives

• The sale of 30,000 shares by a key executive, even under a 10b5-1 plan, could be perceived negatively by some investors, potentially signaling a lack of confidence.

Risks

• While the filing itself does not detail company-specific risks, insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a potential signal of future challenges or a less optimistic outlook from management.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing, a routine insider transaction report, does not provide information directly related to broader industry trends or competitive landscape for Vita Coco Company, Inc.

Stakeholder Impact

• Shareholders might interpret the insider sale with caution, although the pre-arranged nature of the transaction (10b5-1 plan) and the executive's significant remaining holdings mitigate potential negative sentiment.

Key Dates

Recommendation

While insider selling can sometimes be a negative signal, this transaction was conducted under a Rule 10b5-1 plan, which mitigates concerns about opportunistic selling based on undisclosed information. The Executive Chairman retains a substantial stake in the company, including common stock and a significant number of stock options, indicating continued long-term interest. This single transaction, therefore, does not fundamentally alter the investment thesis for Vita Coco Company, Inc., warranting a 'hold' recommendation for existing investors.

Keywords

Vita Coco, COCO, Michael Kirban, Insider Trading, Stock Sale, Form 4, 10b5-1 Plan, Executive Chairman, Beneficial Ownership